Medications Associated with Hot Flashes
From your medication list, duloxetine (CYMBALTA) and progesterone (PROMETRIUM) are associated with hot flashes as documented side effects. 1, 2
Duloxetine (CYMBALTA)
- Hot flashes (described as "flushing" in clinical trials) occur in approximately 3% of patients taking duloxetine compared to 1% in placebo groups 1
- As an SNRI (serotonin-norepinephrine reuptake inhibitor), duloxetine paradoxically can both cause hot flashes as a side effect and be used to treat hot flashes in some patients 3
- The mechanism behind SNRI-induced hot flashes involves alterations in serotonin and norepinephrine neurotransmission, which can affect thermoregulatory centers 3
Progesterone (PROMETRIUM)
- Clinical trials show that 7% of women taking progesterone experience night sweats compared to 17% in placebo groups 2
- Hot flashes were reported in 11% of women taking progesterone with conjugated estrogens compared to 35% in placebo groups 2
- Paradoxically, progesterone is sometimes used to treat hot flashes, with studies showing it may have an independent effect on relieving hot flashes 4
Other Medications to Consider
- While not on your list, it's worth noting that tamoxifen (a breast cancer medication) is strongly associated with hot flashes, occurring in approximately 81% of women taking it 3
- Raloxifene (another SERM) is also associated with increased hot flash severity and frequency compared to placebo 3
Treatment Options for Medication-Induced Hot Flashes
If hot flashes are problematic:
Non-hormonal pharmacologic options include:
- Gabapentin (900 mg/day) can reduce hot flash severity by 46% compared to 15% with placebo 3
- Venlafaxine (37.5-75 mg/day) can significantly reduce hot flash frequency and severity 3
- Clonidine (0.1 mg/day) may be useful for mild to moderate hot flashes 3
- Fezolinetant is a newer option that avoids the 10-20% treatment withdrawal rate seen with SSRIs/SNRIs 5
Non-pharmacologic approaches include:
Clinical Considerations
When selecting treatment for hot flashes, consider:
- Side effect profiles: SNRIs/SSRIs have 10-20% discontinuation rates due to side effects versus 10% for gabapentin 3
- Onset of action: Most pharmacologic treatments work rapidly (within 1 week) 3
- Drug interactions: Some SSRIs (particularly paroxetine) should be used with caution in women taking tamoxifen due to CYP2D6 inhibition 3
- Comorbidities: SNRIs/SSRIs may be preferred if concurrent depression is present; gabapentin may be preferred if neuropathic pain is present 3
Hot flashes from medications often improve with time as the body adjusts to the medication, but may persist throughout treatment 6
Remember to discuss any concerning symptoms with your healthcare provider before making changes to your medication regimen.